Trial Outcomes & Findings for The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes (NCT NCT00321321)

Results Overview

area under the curve AUC and insulin secretion rate

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

12 participants

Primary outcome timeframe

0 - 90 minutes

Results posted on

2015-07-16

May 2006 - March 2007, Outpatient clinic and advertisement

Withdrawal data not reported

The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes

Baseline characteristics by cohort
Measure	Sulfonylurea n=12 Participants
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	11 Participants n=5 Participants
Age, Categorical >=65 years	1 Participants n=5 Participants
Age, Continuous	55 years STANDARD_DEVIATION 7.6 • n=5 Participants
Sex: Female, Male Female	4 Participants n=5 Participants
Sex: Female, Male Male	8 Participants n=5 Participants
Region of Enrollment Denmark	12 participants n=5 Participants

Timeframe: 0 - 90 minutes

area under the curve AUC and insulin secretion rate

Outcome measures
Measure	Sulfonylurea n=12 Participants
Insulin Secretion	56766 pmol/l * 90 minutes

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Gentofte Hospital, University of Copenhagen

Phone: +4539978474